News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Press Releases

Epigenomics AG: Journal of ‘Cancer Treatment and Research Communications’ Publishes Results of Study with Blood Test Epi proColon(R)

DGAP-News: Epigenomics AG / Key word(s): Scientific publication 11.01.2017 / 08:33 The issuer is solely responsible for the content of this announcement. Press release Journal of “Cancer Treatment and Research Communications” Publishes Results of Study with Blood Test Epi proColon(R) ADMIT Study Results Demonstrate Higher Uptake of a Colorectal Cancer Screening Blood Test Compared to […]

Read more

Epigenomics AG to participate in investor conferences

DGAP-News: Epigenomics AG / Key word(s): Conference 2016-11-14 / 17:48 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG to participate in investor conferences Berlin (Germany) and Germantown, MD (U.S.A.), November 14, 2016 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) today announced that Greg Hamilton, Chief Executive […]

Read more

Epigenomics AG Announces 2016 Third Quarter and Nine Months Financial Results and Reports on Operational Highlights

DGAP-News: Epigenomics AG / Key word(s): 9-month figures 2016-11-09 / 07:00 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Announces 2016 Third Quarter and Nine Months Financial Results and Reports on Operational Highlights – Revenue increased by 83% in Q3 2016 over same period the prior year – […]

Read more

Epigenomics AG: ARUP Laboratories to Offer Epi proColon(R), Epigenomics’ Blood-Based Colorectal Cancer Screening Test

DGAP-News: Epigenomics AG / Key word(s): Product Launch 2016-11-08 / 09:36 The issuer is solely responsible for the content of this announcement. Press release ARUP Laboratories to Offer Epi proColon(R), Epigenomics’ Blood-Based Colorectal Cancer Screening Test Berlin (Germany) and Germantown, MD (U.S.A.), November 8, 2016 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), announced […]

Read more

Epigenomics AG: Journal of the American Medical Association (JAMA) publishes ‘letter to the editor’ that clarifies clinical performance data for Epi proColon(R)

DGAP-News: Epigenomics AG / Key word(s): Scientific publication 2016-10-26 / 14:28 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: Journal of the American Medical Association (JAMA) publishes “letter to the editor” that clarifies clinical performance data for Epi proColon(R) Berlin (Germany) and Germantown, MD (U.S.A.), October 26, 2016 […]

Read more

Congressman Donald M. Payne, Jr. Introduces Bipartisan 2016 Colorectal Cancer Detection Act

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 2016-09-29 / 20:03 The issuer is solely responsible for the content of this announcement. Press release Congressman Donald M. Payne, Jr. Introduces Bipartisan 2016 Colorectal Cancer Detection Act Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests Berlin (Germany) and […]

Read more